Zynerba (NASDAQ: ZYNE) is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for tr...See more
Headquarters:
United States of America
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Year Founded:
2014 (11 years)
Address:
80 W. LANCASTER AVENUE; SUITE 300; DEVON, PA 19333, US
At a glanceLOW
spending power
